Oral Water Ingestion in Heart Transplant Patients
Acute Hemodynamic Effects of Oral Water in a Stable Cardiac Transplant Population
2 other identifiers
interventional
40
1 country
2
Brief Summary
In this study the investigators propose to assess the hemodynamic response to the ingestion of 16 fl oz of water. The investigators will test the hypothesis that water ingestion will increase the systemic vascular resistance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2006
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 22, 2007
CompletedFirst Posted
Study publicly available on registry
December 27, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
October 8, 2025
October 1, 2025
23.9 years
December 22, 2007
October 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in total vascular resistance
TPR measured by Modelflow
40 min (before to 30 min after water ingestion
Secondary Outcomes (3)
blood pressure
40 min
heart rate
40 min
plasma norepinephrine
40 minutes
Study Arms (1)
1
EXPERIMENTALwater ingestion (16 fl oz within 3 minutes)
Interventions
Eligibility Criteria
You may qualify if:
- s/p cardiac transplantation scheduled for clinical right heart catheterization
- age \> 18 years
You may not qualify if:
- significant tricuspid regurgitation
- inability to safely swallow 500 ml of water
- other major medical comorbidities such as advanced renal disease where water ingestion may be harmful to patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Satish R. Rajlead
- National Center for Research Resources (NCRR)collaborator
Study Sites (2)
Tennessee Valley Health Systems (Nashville VA)
Nashville, Tennessee, 37212, United States
Vanderbilt University
Nashville, Tennessee, 37232, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Satish R Raj, MD, MSCI
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor of Medicine & Cardiology
Study Record Dates
First Submitted
December 22, 2007
First Posted
December 27, 2007
Study Start
January 1, 2006
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2029
Last Updated
October 8, 2025
Record last verified: 2025-10